GlassScriptPhysician profile
Gregory Kelley
NPI 1891180113
$3,103.56
in general payments reported to CMS, 2019-2025
15 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 93% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
See the full distribution for Sports Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $69.74 · 2023: $116 · 2024: $1,460 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,501 · Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,501.10 |
| Food and Beverage | $413.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $1,921.70 | 2024-2025 | |
| Arthrex, INC. | $759.55 | 2024-2025 | |
| Abbvie INC. | $83.82 | 2023-2025 | |
| Boston Scientific Corporation | $67.96 | 2021-2024 | |
| Allergan, INC. | $55.19 | 2021-2022 | |
| Davol INC. | $36.42 | 2025 | Surgiphor |
| Ibsa Pharma INC. | $28.73 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $27.60 | 2022 | |
| Innovation Technologies INC | $22.45 | 2023 | Irrisept |
| Treace Medical Concepts, INC. | $20.02 | 2023 | |
| Depuy Synthes Sales INC. | $19.23 | 2023 | Orthovisc, Monovisc |
| Ferring Pharmaceuticals INC. | $16.25 | 2022 | |
| Si-Bone, INC. | $15.61 | 2023 | |
| Horizon Therapeutics Plc | $14.82 | 2021 | |
| Bioventus LLC | $14.21 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.